ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 原著論文

Hyperfractionated Radiotherapy with Concurrent Docetaxel for Advanced Head and Neck Cancer: A Phase II Study

https://repo.qst.go.jp/records/46511
https://repo.qst.go.jp/records/46511
641d4e36-c65e-4662-9f53-d267fea88eb8
Item type 学術雑誌論文 / Journal Article(1)
公開日 2013-03-28
タイトル
タイトル Hyperfractionated Radiotherapy with Concurrent Docetaxel for Advanced Head and Neck Cancer: A Phase II Study
言語
言語 eng
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_6501
資源タイプ journal article
アクセス権
アクセス権 metadata only access
アクセス権URI http://purl.org/coar/access_right/c_14cb
著者 Karasawa, Kumiko

× Karasawa, Kumiko

WEKO 463496

Karasawa, Kumiko

Search repository
Matsumoto, Fumihiko

× Matsumoto, Fumihiko

WEKO 463497

Matsumoto, Fumihiko

Search repository
Ito, Shin

× Ito, Shin

WEKO 463498

Ito, Shin

Search repository
Oba, Shinichi

× Oba, Shinichi

WEKO 463499

Oba, Shinichi

Search repository
Furuya, Tomohisa

× Furuya, Tomohisa

WEKO 463500

Furuya, Tomohisa

Search repository
Hirowatari, Hisako

× Hirowatari, Hisako

WEKO 463501

Hirowatari, Hisako

Search repository
Izawa, Hiromi

× Izawa, Hiromi

WEKO 463502

Izawa, Hiromi

Search repository
Ito, Kana

× Ito, Kana

WEKO 463503

Ito, Kana

Search repository
Sasai, Keisuke

× Sasai, Keisuke

WEKO 463504

Sasai, Keisuke

Search repository
唐澤 久美子

× 唐澤 久美子

WEKO 463505

en 唐澤 久美子

Search repository
笹井 啓資

× 笹井 啓資

WEKO 463506

en 笹井 啓資

Search repository
抄録
内容記述タイプ Abstract
内容記述 Aim: To evaluate the value of hyperfractionated radiotherapy with concurrent use of low-dose docetaxel in locally-advanced head and neck squamous cell cancer (HNSCC). Patients and Methods: Patients eligible for this study had confirmed diagnosis of HNSCC stages II (>10 cm3) to IVB. Radiotherapy was delivered twice daily at 1.2 Gy/fraction to a total dose of 72.0 Gy. Docetaxel (10 mg/m2) was administered weekly during radiotherapy. Results: From March 2003 to October 2008, 70 patients were treated. Primary sites included the oropharynx (n=25), hypopharynx (n=24), larynx (n=18), and other sites (n=3). Major grade 3 acute toxicities included mucositis (n=43) and treatment-related pain (n=20). The median follow-up period for surviving patients was 43 months. The 5-year local control rate and overall survival rate were 62.6% and 61.6%, respectively. Conclusion: This modality is a valuable treatment option for the management of locally-advanced HNSCC.
書誌情報 Anticancer Research

巻 32, 号 9, p. 4013-4018, 発行日 2012-09
ISSN
収録物識別子タイプ ISSN
収録物識別子 0250-7005
戻る
0
views
See details
Views

Versions

Ver.1 2023-05-15 23:50:54.058743
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3